California's low-cost insulin plans receive $100m manufacturing boost

Governor Newsom unveils plans to work with a CMO to produce low-cost insulin, as most big pharma insulin is currently produced in-house.

Related Keywords

France ,Germany ,Japan ,United Kingdom ,Italy ,California ,United States ,Canada ,Spain ,Gavin Newsom ,Sanofi Lantus ,Eli Lilly Humalog ,Novo Nordisk Novolog ,Newsom Calrx Biosimilar ,Eli Lilly ,Allan Coukell ,Twitter ,California Department Of Health Care Access ,Diabetes Research Foundation ,Tablet Press Manufacture For Compaction Simulation ,Amphastar Pharmaceuticals ,Mannkind Corp Afrezza ,Us Senate Finance Committee ,Novo Nordisk ,California Governor Gavin Newsom ,California Governor Gavin ,Health Care Access ,Calrx Biosimilar Insulin ,Affordable Insulin Act ,Pharmaceutical Technology ,Juvenile Diabetes Research Foundation ,New York Headquartered Pfizer Centreone ,Mannkind Corp ,Insulin Value ,Finance Committee ,Cleanroom Supplies ,Press Manufacture ,Compaction Simulation ,Chain Refrigerated ,